Skip to main content
SpringerLink
Log in

Avastin's market share threatened by novel agents' survival benefits

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Avastin's market share threatened by novel agents' survival benefits. Pharmacoecon. Outcomes News 594, 2 (2010). https://doi.org/10.2165/00151234-201005940-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-201005940-00002

Keywords

Search

Navigation